SCHEMBL677173

SCHEMBL677173

C=CCC1CCC(=O)NC1=O

nearest known ligand 0.49

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
CRBN Q96SW2 18/20 0.49
DDB1 Q16531 3/20 0.49
ALDH1A1 P00352 1/20 0.41
HTT P42858 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20206912 0.81 CRBN (0.46) CRBNDDB1HTT
Succinimide SCHEMBL7975792 0.81 CRBN (0.39) CRBNDDB1ALDH1A1
SCHEMBL288567 0.80 ALDH1A1 (0.44) CRBNDDB1ALDH1A1
SCHEMBL20359431 0.79 CRBN (0.44) CRBNDDB1HTT
SCHEMBL29044524 0.78 ALDH1A1 (0.42) CRBNDDB1ALDH1A1
SCHEMBL8952307 0.78 CRBN (0.43) CRBNDDB1
SCHEMBL9028497 0.76 CRBN (0.42) CRBNDDB1
Boric Acid SCHEMBL4457542 0.74 ALDH1A1 (0.39) ALDH1A1
SCHEMBL24113857 0.74 CRBN (0.57) CRBNDDB1HTT
SCHEMBL21635270 0.74 CRBN (0.53) CRBNDDB1HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 34 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-102449748-A Photolithographically defined contacts to carbon nanostructures UNIV PENNSYLVANIA 2012-05-09 CN claimed
EP-0409481-A2 Graft copolymers and a process for their preparation ROHM AND HAAS COMPANY (US) 1991-01-23 EP claimed
JP-3115434-A None JP disclosed
US-11174271-B2 6-membered uracil isosteres CV6 THERAPEUTICS (NI) LIMITED (GB) 2021-11-16 US disclosed
US-10544105-B2 Deoxyuridine triphosphatase inhibitors containing cyclopropano linkage CV6 THERAPEUTICS (NI) LIMITED (GB) 2020-01-28 US disclosed
US-20190270756-A1 6-MEMBERED URACIL ISOSTERES CV6 THERAPEUTICS (NI) LIMITED (GB) 2019-09-05 US disclosed
US-20180201586-A1 DEOXYURIDINE TRIPHOSPHATASE INHIBITORS CONTAINING CYCLOPROPANO LINKAGE SAI LIFE SCIENCES LIMITED (IN) 2018-07-19 US disclosed
WO-2018098204-A1 6-MEMBERED URACIL ISOSTERES CV6 THERAPEUTICS (NI) LIMITED (GB) 2018-05-31 WO disclosed
US-8957056-B2 Migrastatin analogs in the treatment of cancer SLOAN-KETTERING INSTIUTE FOR CANCER RESEARCH (US) 2015-02-17 US disclosed
US-8835693-B2 Migrastatin analogs and uses thereof SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH (US) 2014-09-16 US disclosed
US-20140011844-A1 MIGRASTATIN ANALOGS AND USES THEREOF SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH (US) 2014-01-09 US disclosed
CN-1036564-C Herbicidal glutarmides ROHM & HAAS (US) 1997-12-03 CN disclosed
EP-0658160-A1 ANTIPSYCHOTIC QUINOLINE DERIVATIVES OF BENZODIOXANMETHYLAMINE AMERICAN HOME PRODUCTS CORPORATION (US) 1995-06-21 EP disclosed
EP-0409481-B1 Graft copolymers and a process for their preparation ROHM & HAAS (US) 1994-09-28 EP disclosed
WO-1994005655-A1 ANTIPSYCHOTIC QUINOLINE DERIVATIVES OF BENZODIOXANMETHYLAMINE AMERICAN HOME PRODUCTS CORPORATION (US) 1994-03-17 WO disclosed
US-5232985-A Blend of polyamide, polyglut imide and graft polymer of amide-glut ROHM AND HAAS COMPANY (US) 1993-08-03 US disclosed
US-5084517-A Polyamides grafted polyglutarimide ionomers for core/shell polymers with impact strength ROHM AND HAAS COMPANY 1992-01-28 US disclosed
JP-H03115434-A GRAFT COPOLYMER AND ITS PRODUCTION ROHM & HAAS CO 1991-05-16 JP disclosed
CN-1049846-A Glutarimide with weeding activity ROHM & HAAS (US) 1991-03-13 CN disclosed
EP-0409481-A2 Graft copolymers and a process for their preparation ROHM AND HAAS COMPANY (US) 1991-01-23 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10544105-B2 Deoxyuridine triphosphatase inhibitors containing cyclopropano linkage DPYD, DUT, TYMP CRBN 3608/4885DDB1 108/4885ALDH1A1 966/4885
US-11174271-B2 6-membered uracil isosteres UNG, DUT, DPYD CRBN 3184/4885DDB1 80/4885ALDH1A1 972/4885
US-20190270756-A1 6-MEMBERED URACIL ISOSTERES UNG, DUT, DPYD CRBN 3184/4885DDB1 80/4885ALDH1A1 972/4885
US-20180201586-A1 DEOXYURIDINE TRIPHOSPHATASE INHIBITORS CONTAINING CYCLOPROPANO LINKAGE DUT, DPYD, TYMP CRBN 3374/4885DDB1 88/4885ALDH1A1 1105/4885
US-20140011844-A1 MIGRASTATIN ANALOGS AND USES THEREOF KDR, HMGCR, LPAR3 CRBN 2072/4885DDB1 4207/4885ALDH1A1 1123/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.